AzTrials
AzTrials

PersonalityNCT07101796

Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance

An observational study of Personality and Patient Compliance, run by Peking University First Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Personality, Patient Compliance, Anxiety
What is being tested?
continous positive airway pressure (CPAP)
Type of treatment
Medical device
How many people
200 participants
Where
1 siteChina
Study dates
14 Sep 2024to Aug 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: * Patients with sleep disorders other than sleep disorders and respiratory disorders; * Patients with severe mental diseases (such as schizophrenia, bipolar disorder, paranoid mental disorders, mental retardation associated with mental disorders, mental disorders caused by epilepsy, schizoaffective disorders) and personality disorders; * Patients who are taking sleep-affecting medication. ④ Unable to cooperate with the relevant psychological scales for depression, anxiety, personality, and others. ⑤ Patients who have previously used or are being treated with a non-invasive ventilator. ⑥ Other serious somatic diseases or other conditions that may affect ventilator treatment are unsuitable for enrollment as assessed by the investigator.

Who may be able to join

  • Age: 18~70 years old
  • Suspected OSA based on symptoms such as snoring, waking at night, daytime sleepiness, or requiring OSA screening due to related conditions; or confirmed OSA patients referred for sleep monitoring or CPAP pressure titration.
  • Subjects are conscious, utterly independent in behavioral and cognitive ability, and able to answer questions independently;
  • The patients gave informed consent to the study and cooperated with relevant treatment and evaluation.

Who cannot join

  • Age below 18 or above 70 years old
  • No symptoms suggestive of OSA and no need for OSA screening; or patients without confirmed OSA
  • lacking full independence in behavior and cognitive ability, unable to answer questions independently
  • Patients who did not give informed consent or were unwilling to cooperate with treatment and evaluation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jing Ma, Dr. contact

8613651357974

majjmail@163.com

China1 site, 1 recruiting
  • Respiratory Department of Peking University First Hospital

    Beijing, Beijing Municipality, 10034

    Jing Ma

    Recruiting

Other trials in China

About this study

This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.

Read the detailed description

This study will establish a prospective cohort to conduct the study in two parts.

  1. Through the personality, mood, and sleep questionnaires of patients with suspected OSA and planned sleep monitoring, the differences in personality and treatment choices of the OSA population with different personality characteristics and emotional states through follow-up.
  2. The above investigation and follow-up of patients in the hospital for ventilator pressure treatment were used to observe the effect of differences in personality characteristics and mood status on ventilator treatment acceptance, stress, and compliance indicators.
Being tested
continous positive airway pressure (CPAP)
Keywords
Obstructive sleep apnea, personality, patient compliance, Anxiety, depression, Continuous Positive Airway Pressure (CPAP)
Medical subject headings
Patient Compliance, Anxiety Disorders, Depression, Sleep Apnea, Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • continous positive airway pressure (CPAP)Device

    using CPAP to treat OSA

Study groups in NCT07101796
Study groupRoleWhat they receive
Obstructive sleep apnea (OSA)dignosis OSA according to the sleep study (AHI>=5)
Receives: Device: continous positive airway pressure (CPAP)
non-OSAdignosis OSA according to the sleep study (AHI <5)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Eysenck Personality Questionnaire (EPQ)

    This study adopted the classic short form of the Eysenck Personality Questionnaire - Revised (EPQ-R Short Scale) to assess individual personality traits across four dimensions: Psychoticism (P), Extraversion (E), Neuroticism (N), and Lie Scale (L). Each dimension consists of 12 items, with scores ranging from 0 to 12. Higher scores indicate a stronger presence of the corresponding trait. For example, a higher score on Neuroticism reflects greater emotional instability, while a higher score on Extraversion suggests a more outgoing and active personality

    Measured: At baseline

Secondary outcomes (1)
  1. continuous positive airway pressure (CPAP) compliance

    downloading the data from the CPAP to assess average daily usage duration (in hours) and the number of days used per week. Good adherence is typically defined as using the CPAP device for at least 4 hours per night on 70% or more nights over the past 3 consecutive months.

    Measured: From CPAP initiation to the 3-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2025
  2. Study start14 Sep 2024
  3. Primary completionAug 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07101796
Sponsor's protocol ID
2024432
Status last verified
Jul 2025
First submitted
22 Dec 2024
Last updated
3 Aug 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Personality and Patient Compliance, run by Peking University First Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jing Ma, Dr. (8613651357974, majjmail@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Eysenck Personality Questionnaire (EPQ) (time frame: At baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in